Showing results (21-30 of 387) with videos related to
Sort By:
Pageof 39
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 1, 1995
[The Lee-Carter model of the prognosis of mortality in Germany. Berlin Public Health Research Group--partial project "Goals and Goal Indicators for Public Health in East and West Berlin"]J Haberland, K E BergmannORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|October 26, 1999
Observations on simultaneous perilymphatic motions and cochlear microphonics suppressionE Haberland, H J NeumannAdvances in Experimental Medicine and Biology|January 1, 1983
The kallikrein-kinin system in the acutely-ill: (A) changes in plasma kininogen in acutely-ill patients. (B) the efficacy of pulmonary clearance of bradykininR McConn, F Wasserman, G HaberlandThe Journal of Biological Chemistry|November 25, 1977
Nicotinamide adenine dinucleotide-specific glutamate dehydrogenase of Neurospora crassa. IX. Isolation and sequences of several large cyanogen bromide peptidesM E Haberland, E L SmithTrends in Cardiovascular Medicine|July 21, 2012
Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatmentAnnekathrin Haberland, Gerd Wallukat, Ingolf SchimkeThe Journal of Biological Chemistry|September 12, 1997
Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteursD P Hajjar, M E HaberlandProceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophagesM E Haberland, A M FogelmanBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 21, 2013
[The future incidence of colorectal and lung cancers: results of the calculation of different scenarios for the year 2020]E Nowossadeck, J Haberland, K KraywinkelPharmaceutical Patent Analyst|November 19, 2013
The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptorsAnnekathrin Haberland, Gerd Wallukat, Ingolf SchimkePlos One|December 4, 2025
Advances in deep reinforcement learning enable better predictions of human behavior in time-continuous tasksSabine Haberland, Hannes Ruge, Holger FrimmelPageof 39